MAB8701
Anti-Dengue Virus Type I Antibody, clone 15F3-1
clone 15F3-1, Chemicon®, from mouse
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
| Size/SKU | Availability | Price |
|---|---|---|
100 μg | Check Cart for Availability | $275.00 |
About This Item
UNSPSC Code:
12352203
NACRES:
NA.41
eCl@ss:
32160702
Clone:
15F3-1, monoclonal
Species reactivity:
human
Application:
IF
Citations:
1
biological source
mouse
Quality Segment
antibody form
purified antibody
clone
15F3-1, monoclonal
species reactivity
human
manufacturer/tradename
Chemicon®
technique(s)
immunofluorescence: suitable
isotype
IgG1
shipped in
wet ice
General description
Dengue fever is an acute, mosquito-transmitted viral disease characterized by fever, headache, arthralgia (severe retro-orbital pain), myalgia, rash, nausea, and vomiting. Infections are caused by any of the four closely related, but antigenically distinct virus serotypes (DEN-1, DEN-2, DEN-3, and DEN-4). Infection with one of these serotypes does not provide cross-protective immunity, so persons living in a dengue-endemic area can have four dengue infections during their lifetimes. Dengue is primarily an urban disease of the tropics, and the viruses that cause it are maintained in a cycle that involves humans and Aedes aegypti, a domestic, day-biting mosquito that prefers to feed on humans. Although most dengue infections result in relatively mild illness, some can produce Dengue Hemorrhagic Fever (DHF) or dengue shock syndrome, with children being particularly at risk. Although epidemic outbreaks have been reported since 1779, the incidence has been increasing, with global, multiple serotype pandemics intensifying within the last 15 years. There is no specific antiviral therapy for dengue, but for both classical dengue and dengue hemorrhagic fever, symptomatic and supportive measures are effective. Important risk factors for DHF include the strain and serotype of the virus involved, as well as the age, immune status, and genetic predisposition of the patient.
Immunogen
Dengue type 1 (Hawaiian) virus antigen.
Application
Anti-Dengue Virus Type I Antibody, clone 15F3-1 detects level of Dengue Virus Type I & has been published & validated for use in IF.
Immunofluorescent assay. Final working dilutions must be determined by end user.
Biochem/physiol Actions
Reacts with the Dengue type 1 virus. May show reactivity with Dengue type 2 virus.
Physical form
0.02M Phosphate Buffer, pH 7.6, 0.25M NaCl and 0.1% sodium azide.
Format: Purified
Other Notes
Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.
Legal Information
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
1 of 1
This Item | |||
|---|---|---|---|
| description clone 15F3-1, Chemicon®, from mouse | description clone 5D4-11, Chemicon®, from mouse | description affinity isolated antibody | description affinity isolated antibody |
| clone 15F3-1, monoclonal | clone 5D4-11, monoclonal | clone polyclonal | clone polyclonal |
| biological source mouse | biological source mouse | biological source rabbit | biological source rabbit |
| antibody form purified antibody | antibody form purified antibody | antibody form affinity isolated antibody | antibody form affinity isolated antibody |
| species reactivity human | species reactivity human | species reactivity virus (Rift Valley Fever virus) | species reactivity virus (Rift Valley Fever virus) |
| shipped in wet ice | shipped in wet ice | shipped in wet ice | shipped in wet ice |
| technique(s) immunofluorescence: suitable | technique(s) immunofluorescence: suitable | technique(s) ELISA: suitable | technique(s) ELISA: suitable |
Storage Class
12 - Non Combustible Liquids
wgk
WGK 2
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.